Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
Verena Brüll,Constanze Burak,Birgit Stoffel-Wagner,Siegfried Wolffram,Georg Nickenig,Cornelius Müller,Peter Langguth,Birgit Alteheld,Rolf Fimmers,Stefanie Naaf,Benno F. Zimmermann,Peter Stehle,Sarah Egert +12 more
Reads0
Chats0
TLDR
Investigation of the effects of quercetin after regular intake on blood pressure in overweight-to-obese patients with pre-hypertension and stage I hypertension concluded that supplementation with 162 mg/d quercETin from onion skin extract lowers ABP in patients with hypertension, suggesting a cardioprotective effect of quERCetin.Abstract:
The polyphenol quercetin may prevent CVD due to its antihypertensive and vasorelaxant properties. We investigated the effects of quercetin after regular intake on blood pressure (BP) in overweight-to-obese patients with pre-hypertension and stage I hypertension. In addition, the potential mechanisms responsible for the hypothesised effect of quercetin on BP were explored. Subjects (n 70) were randomised to receive 162 mg/d quercetin from onion skin extract powder or placebo in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 6-week washout period. Before and after the intervention, ambulatory blood pressure (ABP) and office BP were measured; urine and blood samples were collected; and endothelial function was measured by EndoPAT technology. In the total group, quercetin did not significantly affect 24 h ABP parameters and office BP. In the subgroup of hypertensives, quercetin decreased 24 h systolic BP by −3·6 mmHg (P=0·022) when compared with placebo (mean treatment difference, −3·9 mmHg; P=0·049). In addition, quercetin significantly decreased day-time and night-time systolic BP in hypertensives, but without a significant effect in inter-group comparison. In the total group and also in the subgroup of hypertensives, vasoactive biomarkers including endothelin-1, soluble endothelial-derived adhesion molecules, asymmetric dimethylarginine, angiotensin-converting enzyme activity, endothelial function, parameters of oxidation, inflammation, lipid and glucose metabolism were not affected by quercetin. In conclusion, supplementation with 162 mg/d quercetin from onion skin extract lowers ABP in patients with hypertension, suggesting a cardioprotective effect of quercetin. The mechanisms responsible for the BP-lowering effect remain unclear.read more
Citations
More filters
Journal ArticleDOI
Flavonoids: an overview
TL;DR: Current trends of research and development activities on flavonoid relate to isolation, identification, characterisation and functions of flavonoids and finally their applications on health benefits and future research directions are discussed.
Journal ArticleDOI
Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid.
TL;DR: Quercetin, a plant pigment is a potent antioxidant flavonoid and more specifically a flavonol, found mostly in onions, grapes, berries, cherries, broccoli, and citrus fruits, it is a versatile antioxidant known to possess protective abilities against tissue injury induced by various drug toxicities.
Journal ArticleDOI
Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans
TL;DR: It is possible that a lower dosage from plant sources could be effective due to of its higher bioavailability compared to the aglycone form, and studies are needed to evaluate the potential cardiovascular benefits of plants rich in quercetin and kaempferol glycoside conjugates.
Journal ArticleDOI
Neuroprotective Effects of Quercetin in Alzheimer's Disease.
TL;DR: A synopsis of the recent literature exploring the relationship between quercetin and cognitive performance in Alzheimer’s disease and its potential as a lead compound in clinical applications is provided.
Journal ArticleDOI
Current evidence on the effect of dietary polyphenols intake on chronic diseases
Chiara Costa,Aristidis Tsatsakis,Charalampos Mamoulakis,Michele Teodoro,Giusi Briguglio,Emanuela Caruso,Dimitris Tsoukalas,Denisa Margina,Efthimios Dardiotis,Demetrios Kouretas,Concettina Fenga +10 more
TL;DR: This comprehensive review of the current evidence defining the position of polyphenols in the prevention/treatment of human chronic diseases, including prostate cancer and other types of cancer, cardiovascular diseases, diabetes mellitus and neurodegenerative diseases such as Alzheimer's and Parkinson's disease focuses on their ability to modulate multiple signalling transduction pathways involved in the pathophysiology of these diseases.
References
More filters
Journal ArticleDOI
Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
TL;DR: The correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Journal ArticleDOI
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated, and empathy builds trust and is a potent motivator.
Journal ArticleDOI
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
TL;DR: Throughout middle and old age, usual blood pressure is strongly and directly related to vascular (and overall) mortality, without any evidence of a threshold down to at least 115/75 mm Hg.
Journal ArticleDOI
The metabolic syndrome—a new worldwide definition
Journal ArticleDOI
No adjustments are needed for multiple comparisons.
TL;DR: A policy of not making adjustments for multiple comparisons is preferable because it will lead to fewer errors of interpretation when the data under evaluation are not random numbers but actual observations on nature.